Dakota Pharma Limited
Wholesale of pharmaceutical goods
Dakota Pharma Limited contacts: address, phone, fax, email, website, shedule
Address: 25 Park Square West LS1 2PW Leeds
Phone: +44-1436 2668823
Fax: +44-1436 2668823
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Dakota Pharma Limited"? - send email to us!
Registration data Dakota Pharma Limited
Register date: 2005-12-02
Register number: 05643457
Type of company: Private Limited Company
Get full report form global database UK for Dakota Pharma LimitedOwner, director, manager of Dakota Pharma Limited
Marshall Glynn Director. Address: Ford Bank 31 Westgate, Wetherby, West Yorkshire, LS22 6NH. DoB: September 1962, British
Anthony Golombeck Director. Address: 12a Sheepfoot Lane, Prestwich, Manchester, M25 0BN. DoB: February 1955, British
Jobs in Dakota Pharma Limited vacancies. Career and practice on Dakota Pharma Limited. Working and traineeship
Package Manager. From GBP 2400
Project Co-ordinator. From GBP 1200
Responds for Dakota Pharma Limited on FaceBook
Read more comments for Dakota Pharma Limited. Leave a respond Dakota Pharma Limited in social networks. Dakota Pharma Limited on Facebook and Google+, LinkedIn, MySpaceAddress Dakota Pharma Limited on google map
Other similar UK companies as Dakota Pharma Limited: Gmg Property Services Limited | Ramsbrook (uk) Ltd | Broompark Developments Limited | Forth Project Management Ltd | Faugeres House Limited
The company named Dakota Pharma has been registered on 2005/12/02 as a Private Limited Company. The company head office is contacted at Leeds on 25 Park Square West, . Should you have to reach the company by post, the postal code is LS1 2PW. The company registration number for Dakota Pharma Limited is 05643457. The company is classified under the NACe and SiC code 46460 which means Wholesale of pharmaceutical goods. Sun, 31st May 2015 is the last time account status updates were reported. From the moment it began on this market eleven years ago, it has managed to sustain its praiseworthy level of prosperity.
That business owes its accomplishments and unending improvement to exactly two directors, who are Marshall Glynn and Anthony Golombeck, who have been controlling it since 2005.